Japan administers first pioneering stem cell treatment for Parkinson's disease
Audio narration · Coming soon
Japan has administered its first conditionally-approved stem cell treatment for Parkinson's disease. This treatment demonstrated symptom improvement in most patients during a small clinical trial. The announcement marks a significant step in advancing therapeutic options for Parkinson's patients in Japan.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews
